Yifeng buybacks, dividend and steady H1 profit growth lift the stock
Company starts buying back its own shares Yifeng said it will spend 200-300 million yuan buying back its own stock at up to 30.56 yuan a share, to fund employee incentives. By early August it had already bought 1.78 million shares for 39.62 million yuan. Buybacks shrink the shares outstanding and signal management thinks the stock is cheap.
The buyback is the main new capital action supporting the price this period.
First-half profit grew faster than sales First-half revenue rose 3.5% to 12.13 billion yuan and net profit rose about 9.5% to 964 million yuan, helped by cost cuts. The company kept opening stores, ending with 15,239 outlets. Profit growing faster than sales shows the core pharmacy business is still healthy.
The interim results are the fundamental driver behind the stock's move.
Cash dividend announced alongside results Yifeng plans to pay 0.3 yuan per share in cash, about 363 million yuan, or 37.6% of first-half profit. A payout of that size returns real cash to shareholders and supports the shares, though it also means less money kept inside the company for expansion.
The dividend is a new shareholder-return event that supports the price.
Buyback wave shows industry capital returning Yifeng's buyback is part of a broad wave of Shanghai-listed companies buying back stock and insiders raising stakes, with 190 new buyback plans worth up to 55.5 billion yuan this year. This broad flow of company money into the market lifts sentiment for names like Yifeng.
It explains the wider market backdrop that amplifies Yifeng's own buyback.